Revamping the FDA

Revamping the FDA

The Journal of Life Sciences

Agency needs to adopt new tools to do its job in the 21st century.

Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA associate commissioner, argues that as the FDA enters its second hundred years, its mission must change to both protect and advance the public health. And in order to do that, the agency that regulates upwards of 25 percent of the U.S. economy needs new tools, new expertise and more funding.

Featured

Animal health and human health are inextricably linked
  May 15, 2012  
Drug Shortages and the Role of the Middle Man
 April 13, 2012  
Obamacare's Medical Mercenaries
 April 13, 2012  

Social Networks

Receive latest news & event updates
Provide email below:

Like CMPI on Facebook
Follow CMPI on Twitter
Connect with CMPI on LinkedIn
Watch our Videos on CMPI YouTube Channel
Subscribe to Receive CMPI RSS Feeds